Reuters logo
BRIEF-Tetraphase Pharmaceuticals provides regulatory and clinical update for eravacycline
December 19, 2016 / 1:29 PM / a year ago

BRIEF-Tetraphase Pharmaceuticals provides regulatory and clinical update for eravacycline

Dec 19 (Reuters) - Tetraphase Pharmaceuticals Inc:

* Tetraphase Pharmaceuticals provides regulatory and clinical update for eravacycline

* Tetraphase Pharmaceuticals Inc - to submit MAA for eravacycline for treatment of complicated intra-abdominal infections to EMA in second half of 2017

* Phase 3 ignite3 study in complicated urinary tract infections to commence in Q1 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below